Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38,539,454
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
209,109
-
Shares change
-
+53,713
-
Total reported value, excl. options
-
$811,000
-
Value change
-
+$238,187
-
Number of buys
-
3
-
Number of sells
-
-5
-
Price
-
$3.88
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q2 2018
9 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q2 2018.
Co-Diagnostics, Inc. - Common Stock (CODX) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 209,109 shares
of 38,539,454 outstanding shares and own 0.54% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (80,315 shares), HighTower Advisors, LLC (77,542 shares), GEODE CAPITAL MANAGEMENT, LLC (48,285 shares), UBS Group AG (2,208 shares), LADENBURG THALMANN FINANCIAL SERVICES INC. (500 shares), MORGAN STANLEY (259 shares), CITADEL ADVISORS LLC (0 shares), Tower Research Capital LLC (TRC) (0 shares), BlackRock Inc. (0 shares), and DEUTSCHE BANK AG\ (200 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.